Company Overview and News
Lloyds may select a sole winner or decide to split the mandate, the people said. Discussions are still ongoing and another firm could still emerge. Representatives at Lloyds, BlackRock and Schroders declined to comment.
SLFPF LLOY SL LYG LLPH LLPK LLPJ BLK LLPE LLPD LLOBF LLPG LLDTF LLD5 LLD7 LLPC LLD6 LLD1 LLD2 SLFPY
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
KMI.WS ECOR PLNT KMI.PRA PKG AEP NINE ADT GE COF-P GILD TMUS PDYPF SYF XERS JNJ VZ MSFT ADS KZR NNN EIDX FB RF.PRB AVRO RF.PRA HOPE NFLX AXP EHC BAC COF-D SEAS COF-C COF-F KR KS IIIV PNFP AAPL DDOC AEP.PRA SJM INPAP SIX JPM GNE WRK LGEJY KMRFZ DE 39IB KMX COF.WS RF UAL WMT CFIN LGEAF IP AMZN MGTA NTRS HON KMI CIWV GM.WS.A GM.WS.B HCSG GM.WS.C KMR CVB VLKAY LGEIY EBAY EPRT STT SLB BAC DFS LGEPF STM BBY BX BK STM LTXB LGLD SLB GM.WSB FOXA CLW COF.PRG COF.PRH PM STT.PRC STT.PRE NTRSP STT.PRD STT.PRG AUTL COF.PRP DLPH SWKS GS SWK TRTX GM PII COF.PRC COF.PRD DIS NEE COF.PRF IBM MOR F GEC C CMCSA COF FUN FUL CFG HBAN NEE.PRI XEL NEE.PRJ TGT BLK S PPG T NEE.PRC NEE.PRQ NEE.PRR SNE DPZ
The week of July 13 was another wild one for the equity markets. Investors are getting to grapple with a nine-year-old bull market that is facing rising gross domestic product in the United States and a “peak earnings” scenario while global growth is slowing. Also front and center is that the Federal Reserve keeps wanting to raise interest rates as the economy reaches full employment, even as trade war and tariff fears keep arising each week.
Warren Buffett’s grandson Howard is a Columbia University professor. He’s also a big believer in businesses creating social value by collaborating rather than competing with each other. Socially responsible investments, suggests the younger Buffett, are the way of the future.
BLK TIF AAPL MSFT NYTAB K ECL MMM
Stocks were looking for direction on Friday, with mixed results in the major equity index futures this Friday the 13th. Investors have had less faith buying the dips in 2018 than in prior years. Many of those investors also have been concerned about how they want their investments positioned ahead of the midterm elections and into international trade concerns and for the longer-term into 2019 and beyond.
WSM GLMD TWX MS.PRE MS.PRF MS.PRG MS.PRA KGC AVGO MS DGE DGE DEO HL.PRB K TWC BLK XLRN MS.PRI T BK MS.PRK URI HL TRI BRCM
BlackRock, Inc. (BLK - Free Report) is slated to report second-quarter 2018 results on Jul 16, before the opening bell. Its revenues and earnings are projected to grow year over year. In the last reported quarter, the company’s earnings surpassed the Zacks Consensus Estimate. Results benefited from an improvement in revenues, rise in assets under management (AUM) and long-term inflows. Moreover, the company boasts a decent earnings surprise history.
BLK CMA.WS CMA KEY SAM CMPWW
In the last five trading days, bank stocks delivered a bullish performance. While escalating trade war between the United States, China and the European Union continued to weigh on investor sentiments, strong economic data on the domestic front largely mitigated this. The latest job market data lessened the concern that the economy is in the late stage of expansion. This news resulted in rising yield on benchmark 10-year Treasury Notes.
WFCNP COF.PRG COF.PRH CMA.WS COF.WS WFC.PRL COF.PRP WFC.PRJ KEY FITBI SAM CMPWW BAC USB COF-D WFC.PRT COF-C COF-F WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY COF.PRC WFC.PRX COF.PRD WFC.PRW WFC.PRV COF.PRF BBT WFC WFC.WS BAC C COF-P CMA COF OZRK BLK FITB
Sprint Corporation (NYSE:S) has 717 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,964,750,410 shares. Largest shareholders include Softbank Group Corp, Dodge & Cox, Ontario Teachers Pension Plan Board, BlackRock Inc., Vanguard Group Inc, Primecap Management Co/ca/, Odey Asset Management Group Ltd, State Street Corp, Norges Bank, and MIG Capital, LLC.
STT BLK S STT.PRC STT.PRE STT.PRD STT.PRG SFTBF 9984 SFTBY
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
STZ.B KHRNF RCI ACBFF DTK TXCX STZ CGC RCIAF TWMJF ACB BLK APH WEED APHQF OGRMF GWP OGI
Investors have been finding it harder to generate positive returns in 2018 than in 2017 and the few prior years. The bull market is effectively nine years old, and trade wars, rising interest rates and a slowdown in some of the expectations of global growth are some of the variables making it more difficult for investors to decide how to best position their investment portfolio.
BLK CATR CAT TRI DE
Financial services firm Avendus Capital is in the final stage of discussions to acquire IDFC Asset Management Company, sources familiar with the negotiations told Moneycontrol.
BLK 532187 INDUSINDBK
SAO PAULO, July 12 (Reuters) - Planemaker Embraer SA is counting on the votes of public-sector Brazilian shareholders to outweigh any potential investor objections to its tie-up with Boeing SA, two people with knowledge of the matter said.
BLK BOE BA
Planemaker Embraer SA is counting on the votes of public-sector Brazilian shareholders to outweigh any potential investor objections to its tie-up with Boeing SA , two people with knowledge of the matter said.
BLK BOE BA
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
2018-07-06 - Asif
Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...
Silicon Investor Message Boards
This table lists all message boards related to BLK / BlackRock, Inc. on message board site Silicon Investor.
|Blackrock Inc. (BLK)||Berkeley Technology Limited (BLKYY)|
|Anyone follow CBLK?|
as of ET